By Dean Seal
Shares of Hims & Hers Health jumped after the company added former Food and Drug Administration official Deb Autor to its board.
The stock was up 8.8% at $21.02 in Monday trading. Shares have doubled since the start of the year.
The telehealth company said Autor, a former deputy commissioner at the FDA, has joined the board as a director.
Hims & Hers also said it has also hired Janet Stevens, the former chief quality officer of Hillrom, as its global head of quality and safety.
Write to Dean Seal at dean.seal@wsj.com
(END) Dow Jones Newswires
November 18, 2024 13:52 ET (18:52 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.